Ratings Surperformance

Trader
-
Investor
Global
-
Quality
ESG MSCI
A

Ratings ESG MSCI

Ratings Mesa Laboratories, Inc.: Strengths and Weaknesses

Highlights: Mesa Laboratories, Inc.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses: Mesa Laboratories, Inc.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 62.38 times its estimated earnings per share for the ongoing year.
  • The company appears highly valued given the size of its balance sheet.
  • The company is not the most generous with respect to shareholders' compensation.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
  • The company's earnings releases usually do not meet expectations.

Rating Financials

Mesa Laboratories, Inc. SectorUnited States

Fundamentals

Growth

Revenue growth

EPS growth

FCF growth

Profitability

EBITDA Margin

EBIT Margin

Net Margin

Capital Efficiency

ROA

ROCE

-

ROE

Financial Health

-

Gearing

-

Leverage

-

Capital Intensity

Balance sheet growth

-

Long Term balance sheet growth

-

Long term revenue growth

Long term EPS growth

More ratings

Rating Valuation

Mesa Laboratories, Inc. SectorUnited States

Global Valuation

-

Enterprise Value

-

EV/Revenue

-

EV/EBITDA

-

EV/FCF

-

Equity Valuation

P/E

PBR

Dividend Yield

EV/EBIT

-

CAPEX/Revenue

More ratings

Rating Consensus

Mesa Laboratories, Inc. SectorUnited States

Consensus

Analysts' buy/sell recommendations

Analysts' recommendations evolution (1 year)

Analysts' recommendations evolution (4 months)

Analysts' target price

Analysts' target price evolution (1 year)

Analysts' target price evolution (4 months)

Analysts' recommendations evolution (7 days)

Target Price evolution (7 days)

More ratings

Rating Business Predictability

Mesa Laboratories, Inc. SectorUnited States

Visibility

-

Analysts' coverage

Financial estimates divergence

-

Analysts' recommendations divergence

Analysts' Target price divergence

-

Surprise rates

Rating Revisions

Mesa Laboratories, Inc. SectorUnited States

Financial revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

EPS revisions (1 year)

EPS revisions (4 months)

EPS revisions (7 days)

Revenue revisions (7 days)

More ratings


Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
742M
A
- -
169B
BBB
110B
BBB
106B
AA
73.87B
AA
58.98B
AA
51.28B
AAA
48.16B
A
40.84B
AAA
32.21B
BBB
Average 69.09B
AA
Weighted average by Cap.
AA
  1. Stock Market
  2. Stocks
  3. MLAB Stock
  4. Ratings Mesa Laboratories, Inc.